This is a space for the iRIS team to update a running list of release notes for changes made on an ad-hoc, or on a release basis. It will be kept up to date, and shared with the team weekly in our iRIS Project Check In meeting.
March 2020
- References to "local" have been removed from Amendment form.
December 2020
- Reviewer Checklist updated modified
- Help text added to study application
- Updated language in study application and amendment form regarding study population
- Changes Study Application section 7
- Added changes to the Amendment submission form (external site tracked consent option to the list)
- Enable property to require PI sign off on Initial Review, Amendment and Progress Report Forms
- Enable property to only allow one Amendment and Progress Report form to be submitted at a time.
- Indian Health Services (IHS) changes to application
November 2020
- Study App Question 5.22 Updated with new text: Are there any commercial, FDA approved products used as the object of the investigation?If yes, please list each product in the table below.
- Added "Inactive" to the status dropdown list for tables 7.4 and 7.6 and "Relying on a Non-IRB memo" has been added to the outcome templates
October 2020
- Changed language of the Decisionally Impaired Subjects question of the Outcome For, change will only be reflected on submissions that reach the board after the revised form is published.
- DEC outcome letter updated to pull in the type of action the user is submitting: Initial Review, Amendment or Continuing review.
- Added "Deputy Director" role to the Scientific Review Form routing list.
- Renamed "Ad Hoc" Reviewer Role to "Ad Hoc Consultant"
- Updated Study Application Research Site question 4 from "Policy 105 and Policy 109" to "Policy 100".
September 2020
- Non-human Subjects Research Outcome Letter has been revised -
- Changes to Questions 4.6, 4.7, 4.9 within the Non-human Subjects Research Outcome Study Application
- Updated the following letters: Determination Amendment of Exempt Study, Determination Exempt Outcome Letter with the language ""Federal regulations and/or NIH policy require prompt reporting of any non-compliance, including major protocol deviations, or unanticipated problems involving risks to subjects or others, or serious harm involving subjects, to the IRB. "
- Removed of FWA#, Site PI, Phone and Email columns from Section 6.1
- Added reference number to Agenda Reviewer Assignment Notification, Expedited Reviewer Assignment Notification, Process Administrative Reviewer Assignment Notification
- Added submission types: stipulation notification, corrections notification
- Submission types for DEC outcome letters added: Initial Review, Continuing Review, Amendment, and Continuing Review and Amendment
August 2020
- Question Mark Help Icon now has links to the Helpdesk Ticketing System and the Training Email -
- IHS Screening Question added to Study Application - Question 6.2 -
Updated policy from Policy 201 to Policy 103 - Present in Initial Review Submission Form, Amendment Form, Present Progress Report Form
- Study Application question 4.1 updated to remove reference to the now deleted section 6
July 2020
Overview
Content Tools
ThemeBuilder